ATHE
Price
$4.47
Change
+$0.04 (+0.90%)
Updated
Sep 23, 01:44 PM (EDT)
Capitalization
78.82M
GLMD
Price
$1.50
Change
+$0.03 (+2.04%)
Updated
Sep 23, 04:57 PM (EDT)
Capitalization
8.05M
48 days until earnings call
Interact to see
Advertisement

ATHE vs GLMD

Header iconATHE vs GLMD Comparison
Open Charts ATHE vs GLMDBanner chart's image
Alterity Therapeutics
Price$4.47
Change+$0.04 (+0.90%)
Volume$240
Capitalization78.82M
Galmed Pharmaceuticals
Price$1.50
Change+$0.03 (+2.04%)
Volume$661
Capitalization8.05M
ATHE vs GLMD Comparison Chart in %
Loading...
ATHE
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
GLMD
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ATHE vs. GLMD commentary
Sep 24, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ATHE is a StrongBuy and GLMD is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 24, 2025
Stock price -- (ATHE: $4.43 vs. GLMD: $1.47)
Brand notoriety: ATHE and GLMD are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ATHE: 6% vs. GLMD: 29%
Market capitalization -- ATHE: $78.82M vs. GLMD: $8.05M
ATHE [@Biotechnology] is valued at $78.82M. GLMD’s [@Biotechnology] market capitalization is $8.05M. The market cap for tickers in the [@Biotechnology] industry ranges from $98.23B to $0. The average market capitalization across the [@Biotechnology] industry is $1.92B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ATHE’s FA Score shows that 0 FA rating(s) are green whileGLMD’s FA Score has 1 green FA rating(s).

  • ATHE’s FA Score: 0 green, 5 red.
  • GLMD’s FA Score: 1 green, 4 red.
According to our system of comparison, GLMD is a better buy in the long-term than ATHE.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ATHE’s TA Score shows that 4 TA indicator(s) are bullish while GLMD’s TA Score has 4 bullish TA indicator(s).

  • ATHE’s TA Score: 4 bullish, 4 bearish.
  • GLMD’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, both ATHE and GLMD are a good buy in the short-term.

Price Growth

ATHE (@Biotechnology) experienced а -4.53% price change this week, while GLMD (@Biotechnology) price change was +0.68% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +2.94%. For the same industry, the average monthly price growth was +8.31%, and the average quarterly price growth was +48.45%.

Reported Earning Dates

GLMD is expected to report earnings on Nov 10, 2025.

Industries' Descriptions

@Biotechnology (+2.94% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ATHE($78.8M) has a higher market cap than GLMD($8.05M). ATHE YTD gains are higher at: 33.776 vs. GLMD (-53.918). GLMD has higher annual earnings (EBITDA): -7.03M vs. ATHE (-12.19M). ATHE has more cash in the bank: 40.7M vs. GLMD (20.5M). GLMD has less debt than ATHE: GLMD (41K) vs ATHE (155K). ATHE (0) and GLMD (0) have equivalent revenues.
ATHEGLMDATHE / GLMD
Capitalization78.8M8.05M978%
EBITDA-12.19M-7.03M174%
Gain YTD33.776-53.918-63%
P/E RatioN/A0.02-
Revenue00-
Total Cash40.7M20.5M199%
Total Debt155K41K378%
FUNDAMENTALS RATINGS
ATHE vs GLMD: Fundamental Ratings
ATHE
GLMD
OUTLOOK RATING
1..100
683
VALUATION
overvalued / fair valued / undervalued
1..100
86
Overvalued
32
Undervalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
9798
PRICE GROWTH RATING
1..100
3965
P/E GROWTH RATING
1..100
10096
SEASONALITY SCORE
1..100
5090

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

GLMD's Valuation (32) in the Pharmaceuticals Other industry is somewhat better than the same rating for ATHE (86) in the Biotechnology industry. This means that GLMD’s stock grew somewhat faster than ATHE’s over the last 12 months.

GLMD's Profit vs Risk Rating (100) in the Pharmaceuticals Other industry is in the same range as ATHE (100) in the Biotechnology industry. This means that GLMD’s stock grew similarly to ATHE’s over the last 12 months.

ATHE's SMR Rating (97) in the Biotechnology industry is in the same range as GLMD (98) in the Pharmaceuticals Other industry. This means that ATHE’s stock grew similarly to GLMD’s over the last 12 months.

ATHE's Price Growth Rating (39) in the Biotechnology industry is in the same range as GLMD (65) in the Pharmaceuticals Other industry. This means that ATHE’s stock grew similarly to GLMD’s over the last 12 months.

GLMD's P/E Growth Rating (96) in the Pharmaceuticals Other industry is in the same range as ATHE (100) in the Biotechnology industry. This means that GLMD’s stock grew similarly to ATHE’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
ATHEGLMD
RSI
ODDS (%)
Bullish Trend 2 days ago
79%
Bullish Trend 2 days ago
90%
Stochastic
ODDS (%)
Bullish Trend 5 days ago
70%
Bearish Trend 2 days ago
90%
Momentum
ODDS (%)
Bearish Trend 2 days ago
89%
Bullish Trend 2 days ago
90%
MACD
ODDS (%)
N/A
Bullish Trend 2 days ago
83%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
88%
Bullish Trend 2 days ago
84%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
89%
Bullish Trend 2 days ago
81%
Advances
ODDS (%)
N/A
Bullish Trend 6 days ago
85%
Declines
ODDS (%)
Bearish Trend 8 days ago
89%
Bearish Trend 9 days ago
90%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
90%
Bearish Trend 2 days ago
89%
Aroon
ODDS (%)
Bullish Trend 2 days ago
85%
Bearish Trend 2 days ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
ATHE
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
GLMD
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
NCNA4.010.32
+8.67%
NuCana plc
FTEK3.410.23
+7.40%
Fuel Tech
HZO25.730.47
+1.86%
MarineMax
ALVO8.010.13
+1.65%
Alvotech
CHWY37.56-0.93
-2.42%
Chewy

ATHE and

Correlation & Price change

A.I.dvisor indicates that over the last year, ATHE has been loosely correlated with EYPT. These tickers have moved in lockstep 54% of the time. This A.I.-generated data suggests there is some statistical probability that if ATHE jumps, then EYPT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ATHE
1D Price
Change %
ATHE100%
-1.16%
EYPT - ATHE
54%
Loosely correlated
+0.83%
TECX - ATHE
35%
Loosely correlated
+5.34%
GHRS - ATHE
31%
Poorly correlated
+1.50%
GLMD - ATHE
31%
Poorly correlated
+0.68%
CVM - ATHE
30%
Poorly correlated
+3.69%
More

GLMD and

Correlation & Price change

A.I.dvisor indicates that over the last year, GLMD has been loosely correlated with NUVL. These tickers have moved in lockstep 41% of the time. This A.I.-generated data suggests there is some statistical probability that if GLMD jumps, then NUVL could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To GLMD
1D Price
Change %
GLMD100%
+0.68%
NUVL - GLMD
41%
Loosely correlated
+2.91%
HXBM - GLMD
38%
Loosely correlated
N/A
REVB - GLMD
31%
Poorly correlated
-1.30%
ATHE - GLMD
30%
Poorly correlated
-1.16%
RVMD - GLMD
30%
Poorly correlated
+2.00%
More